Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,215 | 442 | 74.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,775 | 4 | 18.5% |
| Consulting Fee | $683.00 | 1 | 4.5% |
| Travel and Lodging | $309.41 | 4 | 2.1% |
| Education | $37.40 | 8 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SANOFI-AVENTIS U.S. LLC | $2,807 | 29 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $1,998 | 26 | $0 (2022) |
| Novo Nordisk Inc | $1,501 | 74 | $0 (2024) |
| Lilly USA, LLC | $896.12 | 48 | $0 (2024) |
| Medtronic, Inc. | $840.26 | 35 | $0 (2023) |
| Dexcom, Inc. | $680.49 | 38 | $0 (2024) |
| PFIZER INC. | $647.43 | 4 | $0 (2019) |
| Medtronic MiniMed, Inc. | $610.73 | 23 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $595.60 | 26 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $403.02 | 17 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,187 | 39 | Corcept Therapeutics ($275.23) |
| 2023 | $1,018 | 54 | Medtronic, Inc. ($238.25) |
| 2022 | $1,648 | 65 | Medtronic, Inc. ($416.69) |
| 2021 | $1,191 | 49 | DEXCOM, INC. ($211.89) |
| 2020 | $593.10 | 24 | AstraZeneca Pharmaceuticals LP ($177.18) |
| 2019 | $2,616 | 73 | SANOFI-AVENTIS U.S. LLC ($765.57) |
| 2018 | $2,831 | 73 | SANOFI-AVENTIS U.S. LLC ($1,262) |
| 2017 | $3,936 | 82 | AstraZeneca Pharmaceuticals LP ($1,465) |
All Payment Transactions
459 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $22.21 | General |
| Category: Endocrinology | ||||||
| 12/10/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $7.17 | General |
| Category: Insulin Pump | ||||||
| 11/12/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: Diabetes | ||||||
| 11/05/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: Bone Health | ||||||
| 10/18/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $29.14 | General |
| Category: Endocrinology | ||||||
| 09/25/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: Endocrinology | ||||||
| 09/24/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/20/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $26.93 | General |
| Category: Diabetes | ||||||
| 09/19/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $104.09 | General |
| Category: Neuropsychiatry | ||||||
| 09/06/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $27.26 | General |
| Category: Endocrinology | ||||||
| 09/03/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $21.54 | General |
| Category: Inflammation/Rare Disease | ||||||
| 08/27/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $21.05 | General |
| Category: Diabetes | ||||||
| 08/14/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $33.39 | General |
| Category: Endocrinology | ||||||
| 08/09/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $32.19 | General |
| Category: Cardio-renal | ||||||
| 06/27/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.97 | General |
| Category: Diabetes | ||||||
| 06/26/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $27.04 | General |
| Category: Endocrinology | ||||||
| 06/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SYNJARDY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: DIABETES | ||||||
| 06/11/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $13.09 | General |
| Category: Insulin Pump | ||||||
| 06/10/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $21.55 | General |
| Category: Endocrinology | ||||||
| 06/04/2024 | ZOLL Medical Corporation | Defibrillator (Device) | Food and Beverage | Cash or cash equivalent | $35.31 | General |
| Category: Resuscitation | ||||||
| 05/21/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $25.40 | General |
| Category: UROLOGY | ||||||
| 05/16/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $24.07 | General |
| Category: Cardio-renal | ||||||
| 05/15/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $5.92 | General |
| Category: Insulin Pump | ||||||
| 05/06/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $9.21 | General |
| Category: Insulin Pump | ||||||
| 05/01/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $25.82 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 339 | 734 | $176,831 | $63,415 |
| 2022 | 7 | 304 | 621 | $101,280 | $46,491 |
| 2021 | 7 | 366 | 939 | $173,358 | $75,004 |
| 2020 | 9 | 687 | 1,474 | $262,040 | $95,318 |
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 164 | 466 | $96,567 | $32,928 | 34.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 80 | 128 | $38,400 | $13,148 | 34.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 43 | 53 | $18,502 | $7,843 | 42.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 18 | 53 | $12,922 | $5,386 | 41.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 34 | 34 | $10,440 | $4,110 | 39.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 171 | 460 | $68,540 | $31,231 | 45.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 50 | 66 | $14,816 | $6,778 | 45.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 28 | 28 | $7,756 | $3,703 | 47.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 18 | 19 | $6,194 | $3,249 | 52.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 11 | 22 | $2,574 | $1,351 | 52.5% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 15 | 15 | $1,125 | $143.45 | 12.8% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2022 | 11 | 11 | $275.00 | $35.39 | 12.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 154 | 390 | $72,289 | $30,330 | 42.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 66 | 359 | $50,649 | $22,409 | 44.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 60 | 65 | $24,742 | $10,985 | 44.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 39 | 50 | $12,110 | $5,500 | 45.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 15 | 41 | $8,168 | $3,670 | 44.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 14 | 14 | $4,900 | $2,045 | 41.7% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2021 | 18 | 20 | $500.00 | $65.60 | 13.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 106 | 615 | $92,250 | $38,840 | 42.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 204 | 449 | $89,800 | $25,562 | 28.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 110 | 120 | $48,000 | $21,023 | 43.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 56 | 58 | $14,500 | $4,498 | 31.0% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 18 | 18 | $5,700 | $2,262 | 39.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 18 | 23 | $4,600 | $2,106 | 45.8% |
About Dr. Luis Quintero, MD
Dr. Luis Quintero, MD is a Specialist healthcare provider based in Coral Gables, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1710073648.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Luis Quintero, MD has received a total of $15,020 in payments from pharmaceutical and medical device companies, with $1,187 received in 2024. These payments were reported across 459 transactions from 47 companies. The most common payment nature is "Food and Beverage" ($11,215).
As a Medicare-enrolled provider, Quintero has provided services to 1,696 Medicare beneficiaries, totaling 3,768 services with total Medicare billing of $280,228. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Other Specialties Diabetes & Metabolism
- Location Coral Gables, FL
- Active Since 10/05/2006
- Last Updated 03/12/2025
- Taxonomy Code 174400000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1710073648
Products in Payments
- FARXIGA (Drug) $1,594
- NO PRODUCT DISCUSSED (Drug) $683.00
- TOUJEO (Drug) $621.50
- Minimed Paradigm Revel (Device) $610.73
- SOLIQUA 100/33 (Drug) $593.53
- LANTUS (Drug) $500.00
- Dexcom G6 Transmitter (Medical Supply) $468.60
- Victoza (Drug) $446.96
- Kerendia (Drug) $403.02
- JARDIANCE (Drug) $383.30
- Korlym (Drug) $353.28
- Ozempic (Drug) $327.61
- TRADJENTA (Drug) $325.44
- Omnipod (Device) $319.79
- t-slim insulin pump (Device) $304.86
- MINIMED 770G (Device) $284.24
- JANUVIA (Drug) $259.90
- INPEN SMART INSULIN DELIVERY SYSTEM (Device) $250.99
- INGREZZA (Drug) $244.09
- Tresiba (Drug) $242.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Coral Gables
Paul Perito, Md, MD
Specialist — Payments: $4.5M
Mr. Oscar Hevia, M.d, M.D
Specialist — Payments: $43,109
Dr. Shevanti Jegasothy, M.d, M.D
Specialist — Payments: $20,053
Michelle Barnes Bonilla, M.d, M.D
Specialist — Payments: $6,824
Pedro Juan, M.d, M.D
Specialist — Payments: $4,478
Dr. Juan Aguilar, M.d, M.D
Specialist — Payments: $3,625